(Q44356871)

2 December 2017

title

[3-(1H-imidazol-4-yl)propyl]guanidines containing furoxan moieties: a new class of H3-antagonists endowed with NO-donor properties (English)

1 reference

2 December 2017

3

1 reference

2 December 2017

8

1 reference

2 December 2017

Massimo Bertinaria

1

0 references

Antonella Di Stilo

series ordinal

2

object named as

Antonella Di Stilo

1 reference

2 December 2017

7

Gabriella Coruzzi

1 reference

2 December 2017

6

Cristina Pozzoli

1 reference

2 December 2017

Giovanni Sorba

4

1 reference

2 December 2017

Enzo Poli

series ordinal

5

1 reference

2 December 2017

Alberto Gasco

series ordinal

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Bioorganic & Medicinal Chemistry

2 December 2017

published in

1 reference

2 December 2017

volume

11

1 reference

2 December 2017

issue

7

1 reference

2 December 2017

page(s)

1197-1205

1 reference

Nitric oxide donors: chemical activities and biological applications

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

Nitric oxide (NO)-related pharmaceuticals: contemporary approaches to therapeutic NO modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

Nitro-aspirin (NCX4016) reduces brain damage induced by focal cerebral ischemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

NO-steroids: potent anti-inflammatory drugs with bronchodilating activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

Heterocyclic NO prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

Water Soluble Furoxan Derivatives as NO Prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

A new class of ibuprofen derivatives with reduced gastrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

The histamine H3 receptor and its ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

Identification of rat H3 receptor isoforms with different brain expression and signaling properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

Nitric oxide: a new paradigm for second messengers.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

Effect of some new histamine H2-receptor antagonists on the guinea-pig papillary muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

[125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900651-X

7 January 2021

10.1016/S0968-0896(02)00651-X

Identifiers

DOI

1 reference

2 December 2017

1 reference